[The use of blood plasma with elevated titers of antibodies to Re-chemotype glycolipid in peritonitis]. 1990

A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded

The article analyzes the possibility of immunotherapy of septic complications in cases of peritonitis caused by gram-negative bacteria. A strictly inverse correlation between the severity of intoxication and the level of antibodies to glycolipid Re in blood serum has been established. About 5% of healthy nonimmunized donors have elevated Re-antibody titers (1:128 and higher) in their blood plasma. Screening of blood preparations from more than 1000 donors permitted the creation of the blood plasma bank used for the treatment of peritonitis patients. Immunotherapy of such patients has made it possible to decrease almost two-fold the death rate and to reduce the severity and duration of the intoxication syndrome in patients, as well as to improve the results of the treatment of peritonitis.

UI MeSH Term Description Entries
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
January 1996, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
January 1992, Acta paediatrica (Oslo, Norway : 1992),
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
January 1998, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
November 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
January 2001, European neurology,
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
April 2008, European journal of immunology,
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
August 1950, The American journal of the medical sciences,
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
January 2011, Revista brasileira de hematologia e hemoterapia,
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
November 2013, Clinical neurology and neurosurgery,
A V Apollonin, and A A Rudik, and E I Kropacheva, and V G Likhoded
May 1976, Infection and immunity,
Copied contents to your clipboard!